Nitrous oxide and Meropenem drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nitrous oxide (nitrous oxide) and Meropenem (meropenem). Common drug interactions include acute pulmonary oedema among females and drug-induced liver injury among males.

The phase IV clinical study analyzes what interactions people have when they take Nitrous oxide and Meropenem. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Nitrous oxide?

Nitrous oxide has active ingredients of nitrous oxide. eHealthMe is studying from 1,780 Nitrous oxide users. Check the latest studies of Nitrous oxide.

What is Meropenem?

Meropenem has active ingredients of meropenem. eHealthMe is studying from 33,295 Meropenem users. Check the latest studies of Meropenem.

On Jul, 31, 2026

20 people who take Nitrous oxide and Meropenem together, and have interactions are studied.

Nitrous oxide and Meropenem drug interactions.

What are the common drug interactions of Nitrous Oxide and Meropenem, by gender? *:

female:

Acute pulmonary oedema (sudden deposit of fluid in the lung))
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Dyspnoea (difficult or laboured respiration)
Pulmonary embolism (blockage of the main artery of the lung)
Pyrexia (fever)
Syncope (loss of consciousness with an inability to maintain postural tone)
Anaemia megaloblastic (disorder of abnormally large red blood cells)
Febrile neutropenia (fever with reduced white blood cells)
Anaemia (lack of blood)

male:

Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
Hepatorenal syndrome (renal failure in patients with advanced chronic liver disease)
Pulmonary hypertension (increase in blood pressure in the lung artery)
Pyrexia (fever)
Respiratory disorder (respiratory disease)
Sepsis (a severe blood infection that can lead to organ failure and death)
Tachypnoea (a condition of rapid breathing over 20 per minute)
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Anaemia (lack of blood)
Citrobacter infection (infection by citrobacter (bacteria))

What are the common drug interactions of Nitrous Oxide and Meropenem, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Anaemia megaloblastic (disorder of abnormally large red blood cells)
Febrile neutropenia (fever with reduced white blood cells)
Anaemia (lack of blood)
Neutropenia (an abnormally low number of neutrophils)

40-49:

Rash morbilliform (a rash that looks like measles)

50-59:

Acute pulmonary oedema (sudden deposit of fluid in the lung))
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Dyspnoea (difficult or laboured respiration)
Pulmonary embolism (blockage of the main artery of the lung)
Pyrexia (fever)
Syncope (loss of consciousness with an inability to maintain postural tone)

60+:

Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
Hepatorenal syndrome (renal failure in patients with advanced chronic liver disease)
Pulmonary hypertension (increase in blood pressure in the lung artery)
Pyrexia (fever)
Respiratory disorder (respiratory disease)
Sepsis (a severe blood infection that can lead to organ failure and death)
Tachypnoea (a condition of rapid breathing over 20 per minute)
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Anaemia (lack of blood)
Citrobacter infection (infection by citrobacter (bacteria))

What are the existing conditions these people have? *

Sepsis (a severe blood infection that can lead to organ failure and death): 10 people, 50.00%
Type 2 Diabetes: 9 people, 45.00%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 9 people, 45.00%
Tachyarrhythmia (disturbance of the heart rhythm in which the heart rate is abnormally increased): 9 people, 45.00%
Hyperlipidaemia (presence of excess lipids in the blood): 9 people, 45.00%
High Blood Pressure: 9 people, 45.00%
Sedation: 8 people, 40.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 8 people, 40.00%
Pneumonia: 6 people, 30.00%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 5 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Nitrous oxide and Meropenem?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously